| Diane Joan Irwin, LCSW | |
|
419 E 7th St #207, The Dalles, OR 97058 | |
| (541) 296-5228 | |
| Not Available |
| Full Name | Diane Joan Irwin |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 419 E 7th St #207, The Dalles, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669889143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane Joan Irwin, LCSW Po Box 1114, The Dalles, OR 97058 Ph: (541) 296-5228 | Diane Joan Irwin, LCSW 419 E 7th St #207, The Dalles, OR 97058 Ph: (541) 296-5228 |
News Archive
Rottapharm Madaus and Selvita announced today signature of a services contract for delivery of drug discovery services. The aim of this project is to deliver to Rottapharm Madaus a set of designed and synthesized compounds, including their optimized synthesis route, which will have a therapeutic potential in an indicated area.
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients - receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 8 days ago
Todd A Jacobson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 419 E 7th St Ste 207, The Dalles, OR 97058 Phone: 541-296-5452 Fax: 541-296-4792 | |
Ms. Avie Rice Stacy, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1514 E 14th St, The Dalles, OR 97058 Phone: 541-965-1875 | |
Ronald W Wing, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 419 E 7th St Ste 207, The Dalles, OR 97058 Phone: 541-296-5452 Fax: 541-296-4792 | |
Mr. Richard John Friday, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1620 E 12th St, The Dalles, OR 97058 Phone: 541-296-9151 Fax: 541-296-9156 | |
Mrs. Lacey A Nichols, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1210 Dry Hollow Rd Ste 4 1/2, The Dalles, OR 97058 Phone: 541-240-8938 | |
Tiffany Kenslow, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 508 Washington St, The Dalles, OR 97058 Phone: 541-386-2337 | |
Colin S Wood, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 419 E 7th St Ste 207, The Dalles, OR 97058 Phone: 541-296-5452 Fax: 541-296-4792 |